Bridging the Gap Between Remission and Recovery in BPD: Qualitative Versus Quantitative Perspectives

Journal of Personality Disorders
Paul H Soloff

Abstract

The 10-year outcome for patients with borderline personality disorder (BPD) is diagnostic remission in 85% to 93%; however, less than half achieve good social and vocational functioning, and few attain full psychosocial recovery. To assess the gap between diagnostic remission and psychosocial recovery, quantitative measures of outcome were compared with narrative reports of psychosocial functioning in 150 BPD subjects followed prospectively from 2 to 31 years (mean 9.94 years). Subjects with the best and the worst outcomes were compared on symptom changes over time, and on efforts to improve psychosocial functioning. At intake, poor outcome subjects were more impaired than those with good outcomes, with more borderline psychopathology, hospitalizations, and poverty. At follow-up, 53.8% of good outcome subjects complained of continuing problems with depression, 33.3% with anger and impulse control, and 25.6% with unstable relationships. Despite objective measures of improvement, narrative reports documented residual BPD symptoms, comorbidity, and unemployment interfering with psychosocial recovery.

References

Sep 1, 1976·Archives of General Psychiatry·M M Weissman, S Bothwell
Mar 1, 1975·The American Journal of Psychiatry·A T BeckM Kovacs
Jan 1, 1986·Annals of the New York Academy of Sciences·G L Brown, F K Goodwin
Jul 1, 1981·The American Journal of Psychiatry·J G GundersonV Austin
Dec 8, 1998·The American Journal of Psychiatry·M C ZanariniV Reynolds
Feb 7, 2001·The American Journal of Psychiatry·D S BenderJ G Gunderson
Nov 13, 2001·Comprehensive Psychiatry·J Paris, H Zweig-Frank
Jul 26, 2002·Journal of Personality Disorders·Paul H SoloffThomas M Kelly
Aug 1, 1957·Journal of Consulting Psychology·A H BUSS, A DURKEE
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Nov 13, 2004·Journal of Abnormal Psychology·M Tracie SheaMary C Zanarini
Feb 3, 2006·Psychiatric Services : a Journal of the American Psychiatric Association·Donna S BenderJohn G Gunderson
May 2, 2006·The American Journal of Psychiatry·Mary C ZanariniKenneth R Silk
Feb 13, 2007·Comprehensive Psychiatry·Joel ParisIgor Weinberg
Jun 2, 2007·The American Journal of Psychiatry·Mary C ZanariniLauren B McSweeney
Dec 17, 2008·Journal of Personality Disorders·D Bradford Reich, Mary C Zanarini
Nov 6, 2009·Journal of Psychiatric Research·Camilo J RuggeroDiane Young
Apr 7, 2010·The Journal of Clinical Psychiatry·Mark ZimmermanJoseph B McGlinchey
Jun 2, 2010·Psychiatric Services : a Journal of the American Psychiatric Association·Susanne HörzGarrett Fitzmaurice
Mar 5, 2014·Acta Psychiatrica Scandinavica·M C ZanariniG M Fitzmaurice
Feb 13, 2016·The American Journal of Psychiatry·Mary C ZanariniGarrett M Fitzmaurice

❮ Previous
Next ❯

Citations

Feb 12, 2021·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Maaria KoivistoSari Lindeman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.